Published in Am J Surg Pathol on March 01, 2005
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. Oncologist (2012) 0.99
Granulomatous hypophysitis: two case reports and literature review. J Zhejiang Univ Sci B (2009) 0.97
Xanthomatous hypophysitis mimicking a pituitary adenoma: case report and review of the literature. J Oncol (2010) 0.93
T regulatory cells distinguish two types of primary hypophysitis. Clin Exp Immunol (2008) 0.86
Necrotizing infundibulo-hypophysitis: an entity too rare to be true? Pituitary (2012) 0.82
Diagnosis and management of tumor-like hypophysitis: A retrospective case series. Oncol Lett (2015) 0.79
Folliculo-stellate cells of "true dendritic" type are involved in the inflammatory microenvironment of tumor immunosurveillance of pituitary adenomas. Diagn Pathol (2007) 0.75
Xanthomatous hypophysitis associated with autoimmune disease in an elderly patient: A rare case report. Surg Neurol Int (2016) 0.75
In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis. Sci Rep (2017) 0.75
[Hypophysitis : Types and differential diagnosis]. Pathologe (2016) 0.75
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain (2000) 2.90
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Quantification of, visualization of, and compensation for brain shift using intraoperative magnetic resonance imaging. Neurosurgery (2000) 2.49
Intraoperative compensation for brain shift. Surg Neurol (2001) 2.47
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery (1997) 2.37
NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem (1996) 2.29
Detection and prevention of the trigeminocardiac reflex during skull base surgery. Acta Neurochir (Wien) (2007) 2.28
Intraoperative identification of motor areas of the rhomboid fossa using direct stimulation. J Neurosurg (1993) 2.27
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 2.27
Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. Cent Eur Neurosurg (2010) 2.24
Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22
Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet (1998) 2.21
Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab (1995) 2.00
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (2001) 1.94
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol (2007) 1.83
Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol (1999) 1.75
Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg (1997) 1.74
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol (1999) 1.71
Slow rhythmic oscillations of blood pressure, intracranial pressure, microcirculation, and cerebral oxygenation. Dynamic interrelation and time course in humans. Stroke (1996) 1.63
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology (2000) 1.61
p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death Differ (2010) 1.60
Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg (1999) 1.60
Neurovascular relationship at the trigeminal root entry zone in persistent idiopathic facial pain: findings from MRI 3D visualisation. J Neurol Neurosurg Psychiatry (2005) 1.54
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol (2011) 1.48
Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett (1999) 1.46
Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain (2003) 1.45
Patterns of oligodendroglia pathology in multiple sclerosis. Brain (1994) 1.44
Pericollicular surgical approaches to the rhomboid fossa. Part I. Anatomical basis. J Neurosurg (1997) 1.41
Elevated inferior petrosal sinus levels of PTHrP in a patient with Cushing's disease. Clin Endocrinol (Oxf) (2001) 1.40
Remyelination capacity of the MS brain decreases with disease chronicity. Neurology (2009) 1.39
Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol (1999) 1.38
Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol (1996) 1.36
Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neuropathol Exp Neurol (2000) 1.36
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials (2008) 1.31
Trigemino-cardiac reflex in humans initiated by peripheral stimulation during neurosurgical skull-base operations. Its first description. Acta Neurochir (Wien) (2008) 1.29
A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol (2001) 1.21
Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery (1998) 1.20
Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management. Neurosurgery (1993) 1.20
The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol (2000) 1.19
Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry (2004) 1.18
Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol (2007) 1.17
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol (2001) 1.14
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler (1998) 1.11
Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg (2001) 1.10
Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis (1999) 1.10
Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy. Nuklearmedizin (1995) 1.09
Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol (1995) 1.09
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) (2006) 1.07
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol (1998) 1.07
Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 2. Pulsatility indices: normal reference values and characteristics in subarachnoid hemorrhage. Neurosurgery (1993) 1.06
Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol (2008) 1.06
Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) (1999) 1.05
Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun (2001) 1.05
Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology (2002) 1.04
Functional neuronavigation with magnetoencephalography: outcome in 50 patients with lesions around the motor cortex. J Neurosurg (1999) 1.04
Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol (1999) 1.04
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology (2012) 1.04
Coil migration after endovascular coil occlusion of internal carotid artery pseudoaneurysms within the sphenoid sinus. Minim Invasive Neurosurg (2009) 1.04
Continuous electromyography monitoring of motor cranial nerves during cerebellopontine angle surgery. J Neurosurg (2000) 1.04
Adaptation of a hexapod-based robotic system for extended endoscope-assisted transsphenoidal skull base surgery. Minim Invasive Neurosurg (2004) 1.03
Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg (1999) 1.03
Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett (2000) 1.03
Intrasphenoidal encephaloceles--a clinical entity. Acta Neurochir (Wien) (1987) 1.03
Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol (2004) 1.02
Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol (2000) 1.02
The endocrine spectrum of arachnoid cysts in childhood. Pediatr Neurosurg (1999) 1.01
Diffusion tensor imaging and white matter tractography in patients with brainstem lesions. Acta Neurochir (Wien) (2007) 1.01
Simultaneous estradiol and progesterone receptor analysis in meningiomas. Surg Neurol (1986) 1.01
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry (2005) 1.01
Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure (2007) 1.01
Intraoperative magnetic resonance imaging combined with neuronavigation: a new concept. Neurosurgery (2001) 1.01
Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol (1994) 1.01
Factors influencing the application accuracy of neuronavigation systems. Stereotact Funct Neurosurg (2000) 1.01
Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol (2007) 1.01
Human chorionic gonadotrophin immunoactivity in cystic intracranial tumours. Clin Endocrinol (Oxf) (1995) 1.01
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia (2011) 0.99
Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia (2000) 0.99
Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci (2001) 0.98
Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathol (1997) 0.98
Magnetoencephalography in extratemporal epilepsy. J Clin Neurophysiol (2000) 0.97
Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol (1999) 0.97
Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J Neuroimmunol (1997) 0.97
Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother (1998) 0.97
Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology (2008) 0.97